Temporal and spatial dose distribution of radiation pneumonitis after concurrent radiochemotherapy in stage III non-small cell cancer patients.

about

Temporal and spatial dose distribution of radiation pneumonitis after concurrent radiochemotherapy in stage III non-small cell cancer patients.

Item

http://www.wikidata.org/entity/Q47138854

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Temporal and spatial dose dist ...... on-small cell cancer patients.

@en

Temporal and spatial dose dist ...... on-small cell cancer patients.

@nl

type

Item

label

Temporal and spatial dose dist ...... on-small cell cancer patients.

@en

Temporal and spatial dose dist ...... on-small cell cancer patients.

@nl

prefLabel

Temporal and spatial dose dist ...... on-small cell cancer patients.

@en

Temporal and spatial dose dist ...... on-small cell cancer patients.

@nl

P1476

Temporal and spatial dose dist ...... on-small cell cancer patients.

@en

P2093

Heiko Golpon

http://www.w3.org/2001/XMLSchema#string

Michael Bremer

http://www.w3.org/2001/XMLSchema#string

Mohammed Alharbi

http://www.w3.org/2001/XMLSchema#string

Stefan Janssen

http://www.w3.org/2001/XMLSchema#string

P2860

Analysis of clinical and dosimetric factors associated with severe acute radiation pneumonitis in patients with locally advanced non-small cell lung cancer treated with concurrent chemotherapy and intensity-modulated radiotherapy.

Predicting radiation pneumonitis after chemoradiation therapy for lung cancer: an international individual patient data meta-analysis

Prediction of radiation pneumonitis in lung cancer patients: a systematic review.

Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB non-small-cell lung cancer (RTOG 0617): a randomised, two-by-two facto

The impact of induction chemotherapy and the associated tumor response on subsequent radiation-related changes in lung function and tumor response.

Inhalative steroids as an individual treatment in symptomatic lung cancer patients with radiation pneumonitis grade II after radiotherapy - a single-centre experience.

Change in diffusing capacity after radiation as an objective measure for grading radiation pneumonitis in patients treated for non-small-cell lung cancer.

Impact of Intensity-Modulated Radiation Therapy Technique for Locally Advanced Non-Small-Cell Lung Cancer: A Secondary Analysis of the NRG Oncology RTOG 0617 Randomized Clinical Trial.

Patient's quality of life after high-dose radiation therapy for thoracic carcinomas : Changes over time and influence on clinical outcome.

Changes in pulmonary function and influencing factors after high-dose intrathoracic radio(chemo)therapy.

P2888

s13014-017-0898-5

P304

165

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S13014-017-0898-5

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

C Henkenberens

P577

2017-11-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1092508538

http://www.w3.org/2001/XMLSchema#string

P698

29096667

http://www.w3.org/2001/XMLSchema#string

P921

chemoradiotherapy

P932

5667443

http://www.w3.org/2001/XMLSchema#string